IRF2BP1 Gene: Interferon Regulatory Factor 2 Binding Protein 1
Transcriptional coregulator involved in immune response and cancer
Gene Information Card
| Symbol | IRF2BP1 |
|---|---|
| Full Name | Interferon Regulatory Factor 2 Binding Protein 1 |
| Gene Type | Protein coding |
| Chromosomal Location | 19q13.32 |
| NCBI Gene ID | 26145 ncbi.nlm.nih.gov/gene/26145 |
| Ensembl ID | ENSG00000105639 |
| UniProt ID | Q8IU81 |
| OMIM ID | 615421 |
| HGNC ID | 29296 |
| Aliases | IRF-2BP1, CVID25 |
Description
IRF2BP1 encodes a transcriptional coregulator that interacts with interferon regulatory factor 2 (IRF2) and modulates IRF2-mediated transcriptional repression. It is involved in immune response regulation, cell cycle control, and apoptosis. Mutations in IRF2BP1 are associated with common variable immunodeficiency (CVID) and have been implicated in various cancers.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Common variable immunodeficiency (CVID) | Loss-of-function mutations impair IRF2BP1-mediated transcriptional repression, leading to defective B-cell differentiation and antibody production. | PMID: 25574825, ClinVar |
| Colorectal cancer | IRF2BP1 overexpression promotes tumor growth via NF-κB pathway activation. | PMID: 28411305 |
| Hepatocellular carcinoma | IRF2BP1 downregulation correlates with poor prognosis and increased metastasis. | PMID: 31019237 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Lymph node | 12.5 | Medium |
| Spleen | 10.8 | Medium |
| Bone marrow | 8.2 | Medium |
| Lung | 6.1 | Low |
| Liver | 4.3 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK293 | 15.2 | High expression |
| HeLa | 9.8 | Medium expression |
| HepG2 | 7.5 | Medium expression |
| K562 | 5.1 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1?) | Missense | <0.01% | Loss of start codon, likely loss of function |
| c.124C>T (p.Arg42*) | Nonsense | <0.01% | Premature stop, loss of function |
| c.365G>A (p.Arg122Gln) | Missense | 0.02% | Impaired IRF2 binding, reduced transcriptional repression |
Mutation functional classification
Loss of Function (LOF)
Nonsense and frameshift mutations leading to truncated protein or nonsense-mediated decay.
Gain of Function (GOF)
Not reported.
Dominant Negative (DN)
Not reported.
View complete mutation data:
Gene Ontology (GO)
| • transcription corepressor activity (GO:0003714) | • nucleus (GO:0005634) |
| • cytoplasm (GO:0005737) | • negative regulation of transcription (GO:0045892) |
| • immune response (GO:0006955) |
Pathways
• Interferon signaling (Reactome: R-HSA-913531)
• Transcriptional regulation by IRF2 (Reactome: R-HSA-9020958)
Protein Summary
IRF2BP1 is a 584-amino acid protein containing a RING-type zinc finger domain and a nuclear localization signal. It functions as a transcriptional corepressor by recruiting histone deacetylases (HDACs) to IRF2 target promoters. The protein also interacts with NF-κB and modulates inflammatory responses. Alternative splicing generates multiple isoforms.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| IRF2BP1 Knockout HeLa Cell Line | EDJ-KQ34541 | Human | 26145 | Details Get a Quote |
| IRF2BP1 Knockout HCT 116 Cell Line | EDJ-KQ34540 | Human | 26145 | Details Get a Quote |
| IRF2BP1 Knockout A-549 Cell Line | EDJ-KQ34539 | Human | 26145 | Details Get a Quote |
| IRF2BP1 Knockout HEK293 Cell Line | EDJ-KQ8431 | Human | 26145 | Details Get a Quote |